US OptionsDetailed Quotes
LFUS250117P230000
- 0.00
- 0.000.00%
15min DelayTrading Dec 26 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest230.00Strike Price0.00Turnover28.01%IV3.88%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier22DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.2484Delta0.0192Gamma92.03Leverage Ratio-0.1129Theta-0.0334Rho-22.86Eff Leverage0.1863Vega
Littelfuse Stock Discussion
Sign in to post a comment
Hedge fund managers are adjusting their sails in the stock market, redirecting investments from mega-cap technology firms to a diverse array of companies poised to benefit from the artificial intelligence (AI) revolution, a new report from $Goldman Sachs (GS.US)$ reveals.
An analysis of 707 hedge funds, with a mighty $2.7 trillion in equity positions, has highlighted a strategic shift in their stock holdings in 2024 Q1. Thes...
An analysis of 707 hedge funds, with a mighty $2.7 trillion in equity positions, has highlighted a strategic shift in their stock holdings in 2024 Q1. Thes...
37
2
49
LFUS stock is undervalued with a positive outlook not yet fully factored into the price. Financial health should be considered. Now might be a good time to invest as its prosperous future isn't fully reflected in the current price.
1
Recent insider selling at Littelfuse, particularly at current prices, is a negative indicator. The absence of insider buying over the past year and history of sales suggest caution before purchasing Littelfuse shares.
Analysts' sentiment turns bearish post recent results, leading to reduced revenue forecasts and significant cut in earnings per share estimates. Despite downgrades, no long-term impact on Littelfuse's valuation is expected, but it may lag in industry-wide revenue growth.
Littelfuse's high P/E ratio isn't justified by its forecast growth, matching the wider market. The high share price is concerning as future earnings may not support this positive sentiment, risking shareholders' investments and potential investors may pay an unnecessary premium.
Littelfuse's ROCE may not standout, but its consistent return rate suggests it's solid. Its 65% return to shareholders in the last five years indicates the stock is worth researching, despite seeming pricier now.
Based on recent financial data, intrinsic value of stock appears to be $339.38, suggesting that it's undervalued. Future profit growth and higher expected cash flow aren't fully reflected in current share price, making it an attractive investment.
Littelfuse's rapid earnings growth and conservative payout ratio make it a compelling dividend investment. Its ongoing profit reinvestment and potential to increase the payout ratio enhance its appeal. Investment in Littelfuse warrants further investigation.
3
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Vertiv Holdings (VRT.US)$ - up 18.6%
2. $Erie Indemnity (ERIE.US)$ - up 8.7%
3. $Aspen Technology (AZPN.US)$ - up 6.5%
4. $Penske Automotive (PAG.US)$ - up 5.1%
5. $Humana (HUM.US)$ - up 3.7%
6. $Teva Pharmaceutical Industries (TEVA.US)$ - up 3.7%
7. $Encompass Health (EHC.US)$ - up 3.0%
8. $Emerson Electric (EMR.US)$ - up 2.8...
Gap Ups
1. $Vertiv Holdings (VRT.US)$ - up 18.6%
2. $Erie Indemnity (ERIE.US)$ - up 8.7%
3. $Aspen Technology (AZPN.US)$ - up 6.5%
4. $Penske Automotive (PAG.US)$ - up 5.1%
5. $Humana (HUM.US)$ - up 3.7%
6. $Teva Pharmaceutical Industries (TEVA.US)$ - up 3.7%
7. $Encompass Health (EHC.US)$ - up 3.0%
8. $Emerson Electric (EMR.US)$ - up 2.8...
+16
11
3
No comment yet
Kraks : I don't understand how $Walgreens Boots Alliance (WBA.US)$ can gain from AI
Ni Niu : Good question, I wonder top.. Any shifu?